1. Market Research
  2. > Healthcare
  3. > Pathology Market Trends
Biodefense Market Size, Analysis, Trends - Segmented by Product (Anthrax, Botulism, Smallpox, Nuclear) and Geography - Growth, Trends and Forecast (2019 - 2024)

Biodefense Market Size, Analysis, Trends - Segmented by Product (Anthrax, Botulism, Smallpox, Nuclear) and Geography - Growth, Trends and Forecast (2019 - 2024)

  • August 2019
  • 111 pages
  • ID: 5815104
  • Format: PDF
  • Mordor Intelligence LLP
Up to $750 off Until Apr 30th 2021


Table of Contents

Search Inside

Market Overview
The biodefense market is being driven by factors such as the presence of favorable government initiatives, increasing investment by the governments in developed countries and rapid technological advancements.

Governments spend huge sums of money every year on the R&D of vaccines, in order to stay prepared for any bioterrorism attacks. Pharmaceutical companies operating in the biodefense sector have huge opportunities to expand, due to governments’ drive to be prepared for any kind of bioterrorism.

For instance, in 2004, the United States Congress passed the Project BioShield Act, calling for USD 5 billion investment for purchasing vaccines, which can be used in the event of a bioterrorist attack. This act was designed to acquire medical countermeasures to biological, chemical, radiological, and nuclear agents for civilian use. Though the implementation is observed slow, several recommendations and initiatives have been planned, particularly in the matured markets, such as North America. For example, in 2015, 33 recommendations were given by the Blue Ribbon Study Panel, which could quickly act upon to improve the biodefense.

In 2017, more than 50 public and private sector biosecurity stakeholders engaged in a meeting in Johns Hopkins Center, Washington DC, for recommendations toward National Biodefense Strategy and Implementation Plan. In emerging markets, such as India, there are several facilities developing defensive measures to combat biological attack, such as the Defense Research and Development Organization (DRDO). Substantial efforts are being made in preparing the military force for a biological attack. In the past two decades, there has been a gradual increase in the focus toward awareness regarding bioterrorism across all countries, along with several proposals and meeting to combat such activity, which is one of the primary reasons demanding the need of the biodefense market.

Scope of the Report
Bioterrorism is the use of biological agents, which are harmful to mankind. Biodefense constitutes the use of medical measures to protect individuals against bioterrorism – including interventions such as drugs and vaccinations but also research and public health preparations to defend against such biological attacks. There is a growing awareness regarding synthetic biology for using the biological organisms to reduce the burden of diseases for improving agricultural yields.

Key Market Trends
Nuclear Products are Expected to Register a Highest CAGR Over the Forecast Period

The nuclear segment of the market studied is majorly driven by the rising focus of the public agencies on mitigating the risks associated with the chemical, biological, radiological, and nuclear (CBRN) threats and increased funding for biodefense. The nuclear or radiation weapons cause destruction, due to the harmful effects of ionizing radiation, and render damage similar to that caused by explosive bombs. CBRN and explosives constitute weapons of mass destruction (WMD) that have the potential to cause the annihilation of high magnitude.

The Nuclear Threat Initiative (NTI), founded in 2001, is actively involved in developing and implementing projects that bring new strategies, partnerships, and effective actions, in order to reduce the dangers from the nuclear, biological, and chemical weapons. The initiative’s mission is to strengthen global security, by reducing the risk of use and preventing the spread of nuclear, biological, and chemical weapons.

Various agencies, often combined with defense and preparedness initiatives, are spending on curbing the chemical or nuclear threats. Hence, all these initiatives are offering opportunities for the firms involved in the biodefense industry, thereby, propelling the growth of the market studied.

North America Dominates the Market

In the United States, the National Science and Technology Council (NSTC), in the Office of Science and Technology Policy, coordinates science and technology, and one of its topics is biosecurity.
A dedicated website was designed, contributing to a better awareness, which targets the public, academic researchers, scientific societies, biotechnology, and pharmaceutical industries in biological research.
In the United States, the growth is attributed to the increase in government funding to generate and stockpile sufficient vaccines to be used against anthrax through the various initiatives, such as BioShield Act, Biomedical Advanced Research and Development Authority (BARDA), and Joint Program Executive Office for Chemical & Biological Defense.

For instance, the US Department of Health and Human Services announced its plan to spend more than USD 25 million on an anthrax antitoxin, as a part of an emergency preparedness plan in 2018. In May 2018, the Coalition for Epidemic Preparedness Innovations (CEPI) announced that USD 25 million was granted to advance the development of, and to manufacture, vaccines against the Nipah virus (NiV). This funding was provided to major market players, such as Profectus BioSciences Inc. and Emergent BioSolutions Inc.

Competitive Landscape
The market for biodefense consists of the players such as Emergent BioSolutions Inc., Siga Technologies Inc., Ology Bioservices, Elusys Therapeutics, among others. These companies are getting funds from the governments and are developing certain vaccines or products that are beneficial in regards to the national biosecurity. As the government of the United States has planned to increase the funding for biodefense, these companies will benefit from the same in the coming future.

Reasons to Purchase this report:
- The market estimate (ME) sheet in Excel format
- Report customization as per the client’s requirements
- 3 months of analyst support

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
10% Off


  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Cell-free Protein Expression Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

  • $ 4250
  • March 2021
  • 121 pages

The cell-free protein expression market is expected to register a CAGR of nearly 6.1%, during the forecast period, 2019-2024. - The major factors for the growth of the cell-free protein expression market ...

  • World
  • Europe
  • Proteomics
  • Biotechnology
  • Industry analysis
  • Cancer Incidence
  • Biologics Production


Reportlinker.com © Copyright 2021. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on